| биотехнологические лекарственные препараты | biotechnologically-derived medicinal products (The RMP update may be warranted as a result of data submitted with applications such as new or significant change to the indication, a new dosage form, a new route of administration, a new manufacturing process of a biotechnologically-derived product. SEtrans) |
